{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:37:05Z","timestamp":1763156225492,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.endien.2022.02.017","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:09:38Z","timestamp":1649156978000},"page":"178-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity"],"prefix":"10.1016","volume":"69","author":[{"given":"Diego","family":"Meneses","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Olveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Corripio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Carmen","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00edriam","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Calvo-Vi\u00f1uelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucrecia","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vicent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"de-Cos-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2022.02.017_bib0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease \u2013 meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.endien.2022.02.017_bib0170","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.endien.2022.02.017_bib0175","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1007\/s11695-015-1707-6","article-title":"Utility of ultrasound, transaminases, and visual inspection to assess nonalcoholic fatty liver disease in bariatric surgery patients","volume":"25","author":"Petrick","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.endien.2022.02.017_bib0180","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.endien.2022.02.017_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2004.00126.x","article-title":"Hepatic steatosis in obese patients: clinical aspects and prognostic significance","volume":"5","author":"Festi","year":"2004","journal-title":"Obes Rev"},{"key":"10.1016\/j.endien.2022.02.017_bib0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/nyas.12016","article-title":"Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals","volume":"1281","author":"Masuoka","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.endien.2022.02.017_bib0195","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.endien.2022.02.017_bib0200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH \u2013 current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.endien.2022.02.017_bib0205","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.endien.2022.02.017_bib0210","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/j.gastro.2018.07.018","article-title":"Association between magnetic resonance imaging-proton density fat fraction and liver histology features in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis","volume":"155","author":"Wildman-Tobriner","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.endien.2022.02.017_bib0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0034-1371083","article-title":"Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the Longitudinal Assessment of Bariatric Surgery (LABS) study","volume":"34","author":"Kleiner","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.endien.2022.02.017_bib0220","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.endien.2022.02.017_bib0225","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.soard.2017.07.032","article-title":"Benefit\u2013risk of intraoperative liver biopsy during bariatric surgery: review and perspectives","volume":"13","author":"Barbois","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.endien.2022.02.017_bib0230","first-page":"7","article-title":"Consenso Seedo 2007 Para La Evaluaci\u00f3n Del Sobrepeso Y La Obesidad Y El Establecimiento De Criterios De Intervenci\u00f3n Terap\u00e9utica","author":"Rubio","year":"2007","journal-title":"Rev Espa\u00f1ola Obes"},{"key":"10.1016\/j.endien.2022.02.017_bib0235","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.endien.2022.02.017_bib0240","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1053\/j.gastro.2006.02.024","article-title":"The evolution of severe steatosis after bariatric surgery is related to insulin resistance","volume":"130","author":"Mathurin","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.endien.2022.02.017_bib0245","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.endien.2022.02.017_bib0250","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.endien.2022.02.017_bib0255","doi-asserted-by":"crossref","DOI":"10.1007\/s11695-019-03880-x","article-title":"The HAALT non-invasive scoring system for NAFLD in obesity","author":"Sheth","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.endien.2022.02.017_bib0260","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/hep.22241","article-title":"A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients","volume":"47","author":"Campos","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.endien.2022.02.017_bib0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.endien.2022.02.017_bib0270","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11695-010-0118-y","article-title":"A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients","volume":"20","author":"Ulitsky","year":"2010","journal-title":"Obes Surg"},{"key":"10.1016\/j.endien.2022.02.017_bib0275","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1572-0241.2006.01041.x","article-title":"Nonalcoholic fatty liver disease in severely obese subjects","volume":"102","author":"Gholam","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.endien.2022.02.017_bib0280","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.soard.2016.11.028","article-title":"Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity","volume":"13","author":"Tai","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.endien.2022.02.017_bib0285","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s11695-015-1696-5","article-title":"Prevalence of non-alcoholic fatty liver disease and steatohepatitis risk factors in patients undergoing bariatric surgery","volume":"25","author":"Morita","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.endien.2022.02.017_bib0290","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.endien.2022.02.017_bib0295","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/MEG.0000000000001191","article-title":"Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?","volume":"30","author":"Oikonomou","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.endien.2022.02.017_bib0300","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.endien.2022.02.017_bib0305","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.endien.2022.02.017_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-5996-3-3","article-title":"New clinical score to diagnose nonalcoholic steatohepatitis in obese patients","volume":"3","author":"Pulzi","year":"2011","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.endien.2022.02.017_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0034-1371549","article-title":"Liver biopsy at the time of bariatric surgery: a benefit for patients and the medical community","volume":"34","author":"Verna","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.endien.2022.02.017_bib0320","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1055\/a-0784-8827","article-title":"Nonalcoholic steatohepatitis (NASH) \u2013 current treatment recommendations and future developments","volume":"57","author":"Roeb","year":"2019","journal-title":"Z Gastroenterol"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:15:46Z","timestamp":1762866946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018022000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2530018022000361"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2022.02.017","relation":{},"ISSN":["2530-0180"],"issn-type":[{"type":"print","value":"2530-0180"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2022.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}